dactinomycin has been researched along with Hyperlipoproteinemia Type II in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada-Shiba, M; Tajima, S; Yamamoto, A | 1 |
1 other study(ies) available for dactinomycin and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Response of 3-hydroxy-3-methylglutaryl CoA reductase to l-triiodothyronine in cultured fibroblasts from FH homozygotes.
Topics: Cells, Cultured; Cycloheximide; Dactinomycin; Fibroblasts; Homozygote; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Receptors, LDL; Skin; Triiodothyronine | 1995 |